首页> 外文期刊>Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation >Comparison of Two Pretransplant Predictive Models and a Flexible HCT-CI Using Different Cut off Points to Determine Low-, Intermediate-, and High-Risk Groups: The Flexible HCT-CI Is the Best Predictor of NRM and OS in a Population of Patients Undergoing allo-RIC
【24h】

Comparison of Two Pretransplant Predictive Models and a Flexible HCT-CI Using Different Cut off Points to Determine Low-, Intermediate-, and High-Risk Groups: The Flexible HCT-CI Is the Best Predictor of NRM and OS in a Population of Patients Undergoing allo-RIC

机译:两种移植前预测模型和灵活HCT-CI的比较,使用不同的临界点确定低,中和高风险组:灵活的HCT-CI是正在接受治疗的患者群体中NRM和OS的最佳预测指标异位RIC

获取原文
获取原文并翻译 | 示例
           

摘要

Patient comorbidities are being increasingly analyzed as predictors for outcome after hematopoietic stem cell transplantation (HSCT), especially in allogeneic HSCT (Allo-HSCT). Researchers from Seattle have recently developed several pretransplant scoring systems (hematopoietic cell transplantation comorbidity index [HCT-CI] and the Pretransplantation Assessment of Mortality (RAM) model) from large sets of HSCT recipients with the aim of improving nontransplant models, mainly the Charlson Comorbidity Index (CCI). The validation of these comorbidity indexes in other institutions and in different disease and conditioning-related settings is of interest to determine whether these models are potentially applicable in clinical practice and in research settings. We performed a retrospective study in our institution including 194 consecutive reduced-intensity conditioning (RIC) AlloHSCT (allo-RIC) recipients to compare the predictive value of the RAM score, CCI, the original HCT-CI, and the flexible HCT-CI using a different risk group stratification. The median patient pretransplant scores for the HCT-CI, RAM, and CCI were 3.5,22, and 0, respectively. The flexible HCT-CI risk-scoring-system (restratified as: low risk [LR] 0-3 points, intermediate risk [IR] 4-5 points, and high risk[HR] >5 points) was the best predictor for nonreplapse mortality (NRM). The 100-day and 2-year NRM incidence in these risk categories was 4% (95% confidence interval C.I. 2%-11%), 16% (95% C.I. 9%-31%), and 29% (95% C.I. 19%-45%), respectively (P <.001), and 19% (95% C.I. 12%-28%), 33% (95% C.I. 22%-49%), and 40% (95% C.I. 28%-56%), respectively (P =.01). However, we found no predictive value for NRM using neither the original HCT-CI nor the RAM or CCI models. The better predictive capacity for NRM of the flexible HCT-CI than RAM and CCI was confirmed with the c-statistics (c-statistics of 0.672, 0.634, and 0.595, respectively). Regarding the 2-year overall survival (OS), the flexible HCT-CI score categories were also associated with the highest predictive HR. In conclusion, our single-center study suggests that the flexible HCT-CI is a good predictor of 2-year NRM and survival after an allo-RIC.
机译:越来越多地分析患者合并症作为造血干细胞移植(HSCT)后结果的预测指标,尤其是在同种异体HSCT(Allo-HSCT)中。西雅图的研究人员最近从大量HSCT受者中开发了几种移植前评分系统(造血细胞移植合并症指数[HCT-CI]和移植前死亡率评估(RAM)模型),目的是改善非移植模型,主要是Charlson合并症索引(CCI)。在其他机构以及不同疾病和条件相关环境中对这些合并症指数的验证对于确定这些模型是否可能适用于临床实践和研究环境非常重要。我们在我们的机构中​​进行了一项回顾性研究,包括194位连续的低强度调节(RIC)AlloHSCT(allo-RIC)接受者,以比较RAM评分,CCI,原始HCT-CI和使用以下方法的灵活HCT-CI的预测价值不同的风险组分层。 HCT-CI,RAM和CCI患者的移植前中位数分别为3.5、22和0。灵活的HCT-CI风险评分系统(重新定义为:低风险[LR] 0-3分,中风险[IR] 4-5分和高风险[HR]> 5分)是非复发的最佳预测指标死亡率(NRM)。这些风险类别中的100天和2年NRM发生率分别为4%(95%置信区间CI 2%-11%),16%(95%CI 9%-31%)和29%(95%CI) 19%-45%)(P <.001)和19%(95%CI 12%-28%),33%(95%CI 22%-49%)和40%(95%CI 28 %-56%)(P = .01)。但是,我们既没有使用原始的HCT-CI,也没有使用RAM或CCI模型来发现NRM的预测价值。通过c统计量(分别为0.672、0.634和0.595的c统计量)证实了柔性HCT-CI对NRM的预测能力比RAM和CCI更好。关于2年总生存期(OS),灵活的HCT-CI评分类别也与最高的预测HR相关。总之,我们的单中心研究表明,柔性HCT-CI是同种异体RIC后2年NRM和生存率的良好预测指标。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号